MTOR and cancer: Despite AKT/mTOR inhibition being an important strategy for cancer treatment, some mTOR inhibitors, such as ‘rapalogs’, presented a feedback loop activation of the AKT/mTOR axis, becoming cytostatic rather than cytotoxic [218].